英诺特:国际市场拓展方面,公司进一步丰富了东南亚市场产品矩阵

Core Insights - The company has expanded its product matrix in the Southeast Asian market and achieved significant milestones in the European and American markets [2] Market Expansion - In the Southeast Asian market, the company has enriched its product offerings [2] - In Europe, the company obtained CE (IVDR) product registration certificates for two self-testing kits: Human Chorionic Gonadotropin (HCG) and Luteinizing Hormone (LH), becoming one of the few early recipients of such certifications [2] - This marks a breakthrough in the company's C-end business product layout in the European market [2] Regulatory Approvals - In the U.S. market, the company secured FDA 510(k) product registration for the Influenza A/B Antigen Test Kit, laying a crucial foundation for entering the U.S. market [2] Sales Strategy - The company employs a sales model primarily based on distribution, supplemented by direct sales for its hospital-end business [2] - For C-end home testing, the company has established partnerships with major e-commerce platforms such as JD.com, Tmall, and Meituan by opening official flagship stores [2] - Future plans include further expanding sales channels and enhancing brand and product awareness [2]

Innovita Biological Technology -英诺特:国际市场拓展方面,公司进一步丰富了东南亚市场产品矩阵 - Reportify